Mardi Gomberg-Maitland Selected Research

treprostinil

1/2021	Implantable system for treprostinil and lung transplantation: case series from delivery for pulmonary arterial hypertension study.
10/2019	Long-term results of the DelIVery for Pulmonary Arterial Hypertension trial.
12/2017	Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure.
7/2016	Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.
2/2015	Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.
9/2013	One-year experience with intravenous treprostinil for pulmonary arterial hypertension.
7/2012	Takotsubo cardiomyopathy after treatment of pulmonary arterial hypertension.
1/2012	The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension.
9/2011	Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.
4/2008	Bloodstream infections in patients given treatment with intravenous prostanoids.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mardi Gomberg-Maitland Research Topics

Disease

37	Pulmonary Arterial Hypertension 01/2022 - 08/2005
23	Pulmonary Hypertension 01/2021 - 11/2005
6	Heart Failure 01/2020 - 01/2003
6	Connective Tissue Diseases (Connective Tissue Disease) 11/2011 - 03/2006
4	Sepsis (Septicemia) 10/2019 - 04/2008
3	Hypertension (High Blood Pressure) 01/2020 - 12/2013
3	Hypotension (Low Blood Pressure) 03/2015 - 05/2012
3	Vascular Remodeling 04/2008 - 08/2005
2	COVID-19 01/2022 - 04/2020
2	Headache (Headaches) 01/2020 - 02/2015
2	Systemic Scleroderma (Systemic Sclerosis) 09/2017 - 02/2010
2	Congenital Heart Defects (Congenital Heart Defect) 10/2013 - 03/2006
2	Heart Diseases (Heart Disease) 09/2012 - 08/2011
2	Familial Primary Pulmonary Hypertension 11/2011 - 11/2010
2	Vascular Diseases (Vascular Disease) 11/2010 - 02/2010
2	Hypoxia (Hypoxemia) 04/2008 - 02/2008
2	Neoplasms (Cancer) 04/2008 - 02/2008
1	Gastrointestinal Hemorrhage (Hematochezia) 01/2022
1	Pulmonary Embolism 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Cerebral Hemorrhage 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Edema (Dropsy) 01/2020
1	Lacerations 10/2019
1	Exanthema (Rash) 10/2019
1	Thrombosis (Thrombus) 10/2019
1	Abdominal Pain (Pain, Abdominal) 10/2019
1	Right Ventricular Dysfunction 09/2017
1	Pain (Aches) 07/2016
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 05/2016
1	Telangiectasis (Telangiectasia) 04/2016
1	Breast Neoplasms (Breast Cancer) 04/2016
1	Sarcoidosis (Schaumann Disease) 10/2015
1	Chronic Disease (Chronic Diseases) 03/2015
1	Takotsubo Cardiomyopathy 07/2012
1	Right Ventricular Hypertrophy 05/2012
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2012
1	Eisenmenger Complex (Eisenmenger's Syndrome) 11/2011
1	Pericardial Effusion 07/2010
1	Renal Insufficiency (Renal Failure) 07/2010
1	Idiopathic Pulmonary Fibrosis 02/2010
1	Diabetes Mellitus 09/2009

Drug/Important Bio-Agent (IBA)

13	treprostinil FDA Link 01/2021 - 11/2005
9	Epoprostenol (Prostacyclin)FDA LinkGeneric 10/2015 - 08/2005
5	Pharmaceutical PreparationsIBA 10/2020 - 07/2008
4	ProstaglandinsIBA 01/2022 - 04/2008
3	Carbon MonoxideIBA 05/2012 - 02/2010
3	CreatinineIBA 05/2012 - 05/2008
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 02/2010
2	macitentanIBA 10/2018 - 02/2015
2	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2017 - 07/2010
2	Vasodilator Agents (Vasodilators)IBA 10/2015 - 11/2010
2	Endothelin Receptors (Endothelin Receptor)IBA 03/2015 - 12/2006
2	Sildenafil Citrate (Viagra)FDA Link 11/2011 - 11/2005
2	Biomarkers (Surrogate Marker)IBA 09/2011 - 09/2009
1	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	ACE-011IBA 01/2021
1	ambrisentan FDA Link 01/2020
1	Prostaglandins IIBA 12/2017
1	PH.3IBA 09/2017
1	pro-brain natriuretic peptide (1-76)IBA 09/2017
1	Natriuretic PeptidesIBA 09/2017
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 05/2016
1	Ado-Trastuzumab EmtansineIBA 04/2016
1	sitaxsentanIBA 12/2015
1	Ranolazine FDA Link 12/2015
1	Endothelin-1 (Endothelin 1)IBA 12/2015
1	fasudil (AT 877)IBA 08/2015
1	riociguatIBA 02/2015
1	SolutionsIBA 01/2015
1	GadoliniumIBA 02/2012
1	Phosphodiesterase 5 InhibitorsIBA 11/2011
1	vasectrin IIIIBA 09/2011
1	superoxide dismutase 2IBA 06/2010
1	AlbuminsIBA 02/2010
1	Oxygen (Dioxygen)IBA 02/2010
1	Urea (Carbamide)FDA LinkGeneric 09/2009
1	DiureticsIBA 09/2009
1	NitrogenIBA 09/2009
1	Phosphodiesterase InhibitorsIBA 09/2009
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 09/2009
1	Indicators and Reagents (Reagents)IBA 07/2009
1	Sorafenib (BAY 43-9006)FDA Link 04/2008
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 04/2008
1	RNA (Ribonucleic Acid)IBA 04/2008
1	Semaxinib (SU5416)IBA 04/2008

Therapy/Procedure

25	Therapeutics 01/2022 - 08/2005
4	Lung Transplantation 01/2021 - 02/2012
3	Drug Therapy (Chemotherapy) 01/2021 - 12/2014
3	Catheters 10/2019 - 01/2012
1	Blood Transfusion (Blood Transfusions) 01/2022
1	Punctures 10/2019
1	Subcutaneous Infusions 07/2016
1	Critical Care (Surgical Intensive Care) 05/2015
1	Heart-Assist Devices 03/2015
1	Intravenous Infusions 01/2015
1	Aftercare (After-Treatment) 07/2012